Bulletin
Investor Alert

Merck & Co. Inc.

NYS: MRK

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 9, 2022, 7:58 p.m.

MRK
/zigman2/quotes/209956077/composite

$

108.78

Change

0.00 0.00%

Volume

Volume 577,485

Quotes are delayed by 20 min

/zigman2/quotes/209956077/composite

Previous close

$ 110.85

$ 108.78

Change

-2.07 -1.87%

Day low

Day high

$108.75

$111.37

Open

52 week low

52 week high

$71.97

$111.37

Open

Insider Actions for Merck & Co. Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
11/10/2022 Steven C. Mizell
EVP, Chief HR Officer
15,000   Disposition at $101.42 per share. 1,521,300
11/10/2022 Steven C. Mizell
EVP, Chief HR Officer
15,000   Derivative/Non-derivative trans. at $0 per share. 0
11/09/2022 Robert M. Davis
CEO & President; Director
100   Disposition at $103.59 per share. 10,359
11/09/2022 Robert M. Davis
CEO & President; Director
79,918   Disposition at $102.98 per share. 8,229,955
11/09/2022 Robert M. Davis
CEO & President; Director
87,595   Disposition at $101.94 per share. 8,929,434
11/09/2022 Johannes Jacobus Oosthuizen
President, U.S. Market
1,795   Disposition at $103.21 per share. 185,261
11/09/2022 Robert M. Davis
CEO & President; Director
167,613   Derivative/Non-derivative trans. at $0 per share. 0
11/08/2022 Steven C. Mizell
EVP, Chief HR Officer
20,000   Disposition at $101 per share. 2,020,000
11/08/2022 Steven C. Mizell
EVP, Chief HR Officer
20,000   Derivative/Non-derivative trans. at $0 per share. 0
11/07/2022 Kenneth C. Frazier
Executive Chair; Director
84,721   Disposition at $100.07 per share. 8,478,030
11/07/2022 Kenneth C. Frazier
Executive Chair; Director
126,134   Disposition at $99.42 per share. 12,540,242
11/07/2022 Kenneth C. Frazier
Executive Chair; Director
24,914   Disposition at $98.45 per share. 2,452,783
11/07/2022 Johannes Jacobus Oosthuizen
President, U.S. Market
45,561   Disposition at $99.47 per share. 4,531,952
11/07/2022 Kenneth C. Frazier
Executive Chair; Director
235,769   Derivative/Non-derivative trans. at $0 per share. 0
11/07/2022 Johannes Jacobus Oosthuizen
President, U.S. Market
7,045   Derivative/Non-derivative trans. at $0 per share. 0
11/07/2022 Johannes Jacobus Oosthuizen
President, U.S. Market
13,540   Derivative/Non-derivative trans. at $0 per share. 0
11/07/2022 Johannes Jacobus Oosthuizen
President, U.S. Market
17,455   Derivative/Non-derivative trans. at $0 per share. 0
11/07/2022 Johannes Jacobus Oosthuizen
President, U.S. Market
14,703   Derivative/Non-derivative trans. at $0 per share. 0
11/04/2022 Kenneth C. Frazier
Executive Chair; Director
34,810   Disposition at $99.08 per share. 3,448,974
11/04/2022 Kenneth C. Frazier
Executive Chair; Director
200,190   Disposition at $98.53 per share. 19,724,720
11/04/2022 Kenneth C. Frazier
Executive Chair; Director
235,000   Derivative/Non-derivative trans. at $0 per share. 0
11/03/2022 Kenneth C. Frazier
Executive Chair; Director
20,383   Disposition at $99.09 per share. 2,019,751
11/03/2022 Kenneth C. Frazier
Executive Chair; Director
214,617   Disposition at $98.68 per share. 21,178,405
11/03/2022 Kenneth C. Frazier
Executive Chair; Director
235,000   Derivative/Non-derivative trans. at $0 per share. 0
11/02/2022 Kenneth C. Frazier
Executive Chair; Director
94,339   Disposition at $100.4 per share. 9,471,635
11/02/2022 Kenneth C. Frazier
Executive Chair; Director
205,661   Disposition at $99.68 per share. 20,500,288
11/02/2022 Kenneth C. Frazier
Executive Chair; Director
134,172   Derivative/Non-derivative trans. at $0 per share. 0
11/02/2022 Kenneth C. Frazier
Executive Chair; Director
165,828   Derivative/Non-derivative trans. at $0 per share. 0
11/01/2022 Kenneth C. Frazier
Executive Chair; Director
1,470   Gift at $0 per share. 0
11/01/2022 Kenneth C. Frazier
Executive Chair; Director
2,450   Gift at $0 per share. 0
11/01/2022 Kenneth C. Frazier
Executive Chair; Director
1,710   Gift at $0 per share. 0
11/01/2022 Kenneth C. Frazier
Executive Chair; Director
700   Disposition at $101.05 per share. 70,735
11/01/2022 Kenneth C. Frazier
Executive Chair; Director
96,981   Disposition at $100.22 per share. 9,719,435
11/01/2022 Kenneth C. Frazier
Executive Chair; Director
202,319   Disposition at $99.61 per share. 20,152,995
11/01/2022 Kenneth C. Frazier
Executive Chair; Director
300,000   Derivative/Non-derivative trans. at $0 per share. 0
10/31/2022 Kenneth C. Frazier
Executive Chair; Director
229,302   Disposition at $101.03 per share. 23,166,381
10/31/2022 Kenneth C. Frazier
Executive Chair; Director
70,698   Disposition at $99.82 per share. 7,057,074
10/31/2022 Kenneth C. Frazier
Executive Chair; Director
300,000   Derivative/Non-derivative trans. at $0 per share. 0
10/30/2022 Johannes Jacobus Oosthuizen
President, U.S. Market
450   Derivative/Non-derivative trans. at $100.77 per share. 45,346
10/30/2022 Johannes Jacobus Oosthuizen
President, U.S. Market
913   Derivative/Non-derivative trans. at $100.77 per share. 92,003

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
27 Purchases
36 Sales
2,891,615
2,919,636
Last 6 months
27 Purchases
36 Sales
2,891,615
2,919,636
Last 12 months
61 Purchases
58 Sales
3,150,905
2,926,995

Officers and Executives

Mr. Robert M. Davis
Chairman, President & Chief Executive Officer
Ms. Caroline A. Litchfield
Chief Financial Officer & Executive Vice President
Mr. Dave Williams
EVP, Chief Information & Digital Officer
Mr. Sanat Chattopadhyay
EVP & President-Merck Manufacturing Division
Dr. Dean Y. Li
EVP & President-Merck Research Laboratories
Mr. James Matteucci
Associate Director-State Government Affairs
Mr. Michael Klobuchar
Chief Strategy Officer & Executive Vice President
Dr. Tamara N. Elias
Vice President & Head-Global Partnerships
Mr. Allan Gabor
President-Asian-Pacific-BioPharma Business
Ms. Carol Bowden
Med Aff. Dir, Cardiovascular Metabolism, NorCal
Mr. Andre Musto
SVP & Head-Gbl Cardiometabolic & Endoc Franchise
Ms. Brooke Hinkson
Executive Director-Global Clinical Data Standards
Mr. Jannie Oosthuizen
President-Merck Human Health
Ms. Lisa LeCointe-Cephas
Chief Ethics & Compliance Officer, SVP
Ms. Johanna Herrmann
Vice President-Global Communications
Mr. Jacks Lee
Senior Vice President-Manufacturing & Supply
Mr. Joseph Romanelli
President-Human Health International
Dr. Fiona Hamilton Marshall
SVP, Global Head-Discovery Sciences
Mr. Richard R. DeLuca
Executive Vice President & President-Animal Health
Mr. Chirfi Guindo
Chief marketing officer-Human Health
Dr. Eric H. Rubin
Senior VP-Global Clinical Oncology
Ms. Denise Williams
Vice President
Dr. Bruce A. Beutel
Executive Director
Ms. Rita A. Karachun
Senior Vice President-Finance & Global Controller
Mr. Peter Dannenbaum
Vice President-Investor Relations
Mr. Steven C. Mizell
Chief Human Resources Officer & Executive VP
Ms. Kelly E. W. Grez
Secretary
Ms. Sylvia A. Ayler
Legal Director
Ms. Jennifer Zachary
Executive Vice president & General Counsel
Ms. Kathy J. Warden
Independent Director
Dr. Christine E. Seidman
Independent Director
Dr. Risa J. Lavizzo-Mourey
Independent Director
Dr. Stephen L. Mayo
Independent Director
Mr. Douglas M. Baker
Independent Director
Mr. Thomas Henry Glocer
Lead Independent Director
Ms. Patricia Fiorello Russo
Independent Director
Mr. Peter C. Wendell
Independent Director
Ms. Pamela J. Craig
Independent Director
Dr. Paul B. Rothman
Independent Director
Mr. Inge G. Thulin
Independent Director
Ms. Mary Ellen Coe
Independent Director
Link to MarketWatch's Slice.